X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5677) 5677
Newsletter (50) 50
Magazine Article (31) 31
Book Chapter (30) 30
Newspaper Article (8) 8
Dissertation (4) 4
Report (2) 2
Book Review (1) 1
Publication (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5328) 5328
lamivudine - therapeutic use (4271) 4271
science & technology (3806) 3806
life sciences & biomedicine (3657) 3657
male (3000) 3000
female (2845) 2845
adult (2743) 2743
lamivudine (2381) 2381
antiviral agents - therapeutic use (2300) 2300
middle aged (2028) 2028
hepatitis b, chronic - drug therapy (1868) 1868
hiv infections - drug therapy (1802) 1802
anti-hiv agents - therapeutic use (1513) 1513
reverse transcriptase inhibitors - therapeutic use (1498) 1498
drug therapy, combination (1497) 1497
treatment outcome (1368) 1368
infectious diseases (1272) 1272
hepatitis b (1149) 1149
hepatitis b virus - genetics (1123) 1123
gastroenterology & hepatology (1080) 1080
adenine - analogs & derivatives (997) 997
zidovudine - therapeutic use (977) 977
viral load (925) 925
aids/hiv (924) 924
adenine - therapeutic use (900) 900
virology (900) 900
hepatitis b virus - drug effects (871) 871
lamivudine - administration & dosage (864) 864
hepatitis b virus (799) 799
organophosphonates - therapeutic use (794) 794
dna, viral - blood (758) 758
hiv (753) 753
aged (749) 749
hepatitis b - drug therapy (743) 743
mutation (722) 722
pharmacology & pharmacy (719) 719
hepatitis b, chronic - virology (711) 711
tenofovir (705) 705
drug therapy (636) 636
immunology (633) 633
hiv infections - virology (614) 614
adolescent (609) 609
antiviral agents (579) 579
drug resistance, viral (578) 578
cd4 lymphocyte count (577) 577
lamivudine - pharmacology (553) 553
lamivudine - adverse effects (546) 546
retrospective studies (541) 541
health aspects (522) 522
hepatitis b e antigens - blood (518) 518
guanine - analogs & derivatives (483) 483
interferon-alpha - therapeutic use (464) 464
time factors (461) 461
hiv-1 - drug effects (458) 458
hepatitis (437) 437
abridged index medicus (436) 436
guanine - therapeutic use (433) 433
drug resistance (415) 415
stavudine - therapeutic use (411) 411
young adult (397) 397
care and treatment (395) 395
drug resistance, viral - genetics (390) 390
genotype (388) 388
hiv protease inhibitors - therapeutic use (384) 384
microbiology (383) 383
follow-up studies (382) 382
chronic hepatitis b (380) 380
hiv infection (376) 376
anti-hiv agents - administration & dosage (370) 370
liver transplantation (368) 368
hiv-1 - genetics (360) 360
antiretroviral therapy, highly active (357) 357
anti-hiv agents - adverse effects (353) 353
antiviral agents - administration & dosage (353) 353
reverse transcriptase inhibitors - administration & dosage (349) 349
child (345) 345
human immunodeficiency virus--hiv (345) 345
virus diseases (339) 339
hepatitis b surface antigens - blood (336) 336
antiviral agents - pharmacology (332) 332
hepatitis b, chronic - complications (330) 330
alanine transaminase - blood (326) 326
dideoxynucleosides - therapeutic use (326) 326
risk factors (326) 326
analysis (324) 324
research (324) 324
hiv infections - complications (322) 322
drug combinations (318) 318
hepatitis b virus - isolation & purification (317) 317
rna, viral - blood (315) 315
hepatitis b virus - immunology (314) 314
prospective studies (314) 314
hepatitis b - prevention & control (308) 308
hepatitis b - virology (308) 308
interferon (300) 300
zidovudine - administration & dosage (300) 300
hiv infections - immunology (297) 297
antiretroviral therapy (296) 296
antiretroviral drugs (295) 295
general & internal medicine (294) 294
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5368) 5368
Chinese (226) 226
French (80) 80
Spanish (70) 70
German (53) 53
Japanese (48) 48
Korean (45) 45
Portuguese (29) 29
Polish (19) 19
Hungarian (12) 12
Turkish (12) 12
Russian (10) 10
Dutch (9) 9
Italian (9) 9
Czech (5) 5
Danish (3) 3
Romanian (3) 3
Serbian (3) 3
Croatian (2) 2
Arabic (1) 1
Finnish (1) 1
Hebrew (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Mayo Clinic Proceedings, ISSN 0025-6196, 2011, Volume 86, Issue 10, pp. 1009 - 1026
.... This review article is structured to discuss antiviral therapeutics on the basis of these 3 major antiviral categories, with the caveat that some drugs discussed... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Acyclovir - therapeutic use | Foscarnet - pharmacology | Hepatitis C - drug therapy | HIV Infections - epidemiology | Humans | Ganciclovir - analogs & derivatives | Interferons - therapeutic use | Oligopeptides - therapeutic use | Hepatitis - drug therapy | Valacyclovir | Adenine - therapeutic use | Lamivudine - therapeutic use | Ganciclovir - therapeutic use | Proline - pharmacology | Protease Inhibitors - therapeutic use | Guanine - therapeutic use | Oseltamivir - pharmacology | Virus Replication - drug effects | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Valganciclovir | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Comorbidity | Interferons - pharmacology | Pyrimidinones - therapeutic use | Acyclovir - pharmacology | Zanamivir - therapeutic use | Herpesviridae Infections - drug therapy | Thymidine - analogs & derivatives | Valine - therapeutic use | Oligopeptides - pharmacology | Telbivudine | Ribavirin - pharmacology | Guanine - analogs & derivatives | Oseltamivir - therapeutic use | Guanine - pharmacology | Hepatitis C - epidemiology | Nucleosides - pharmacology | Ganciclovir - pharmacology | Pyrimidinones - pharmacology | Influenza, Human - drug therapy | Drug Therapy, Combination | Nucleosides - therapeutic use | Acyclovir - analogs & derivatives | Ribavirin - therapeutic use | Valine - analogs & derivatives | Zanamivir - pharmacology | Adenine - pharmacology | Proline - therapeutic use | Organophosphonates - pharmacology | Hepatitis B, Chronic - drug therapy | HIV Infections - drug therapy | Lamivudine - pharmacology | Foscarnet - therapeutic use | Valine - pharmacology | Amantadine - pharmacology | Antiviral agents | Diagnosis | Research | Drug therapy | HIV infection | Health aspects | Index Medicus | Abridged Index Medicus | Symposium on Antimicrobial Therapy
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 05/2012, Volume 142, Issue 6, pp. 1324 - 1334.e3
With the development of effective therapies against human immunodeficiency virus (HIV), hepatitis C virus (HCV) infection has become a major cause of morbidity... 
Gastroenterology and Hepatology | Drug Interaction | HCV | Treatment | HIV | Liver Disease | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recombinant Proteins - therapeutic use | Coinfection | Antiviral Agents - pharmacokinetics | HIV Infections - epidemiology | Humans | Hepatitis C, Chronic - etiology | Male | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Tenofovir | Deoxycytidine - therapeutic use | Drug Interactions | Homosexuality, Male | Adenine - therapeutic use | Lamivudine - therapeutic use | Anti-HIV Agents - therapeutic use | Dideoxynucleosides - therapeutic use | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Raltegravir Potassium | Substance Abuse, Intravenous - complications | Emtricitabine | Liver Diseases - virology | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Drug Administration Schedule | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Liver Diseases - prevention & control | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Pyrrolidinones - therapeutic use | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Disease Progression | Proline - therapeutic use | HIV Infections - etiology | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Antiviral agents | Medical colleges | Care and treatment | Liver diseases | Comorbidity | Drug interactions | Mortality | Development and progression | Biological response modifiers | HIV (Viruses) | Hepatitis | Protease inhibitors | Proteases | Hepatitis C virus | Hepatitis C | Health aspects | HIV infection | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 07/2015, Volume 15, Issue 7, pp. 775 - 784
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
BMJ Open, ISSN 2044-6055, 09/2017, Volume 7, Issue 9, pp. e019022 - e019022
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 1019 - 1024
Journal Article